Giraudo Bryan

Average Profitability
113.11%
Insider Buys Quantity
11
Insider Buys Sum
$825,312.95
Insider Sells Quantity
3
Insider Sells Sum
$155,062.89

Insider Activity of Giraudo Bryan

According to the SEC Form 4 filings, Giraudo Bryan, being in a position of

  1. COO/CFO at Gossamer Bio, Inc.,
    оver the last 12 months, has bought 300000 shares for $171,990, and sold 6430 shares for $7,431,
    over all time since 2019-02-12, has bought 395111 share for $669,507, and sold 22642 shares for $155,063.

The largest purchase of all time was on 2019-02-12 and amounted to 12000 shares of Gossamer Bio, Inc. for $192,000.

The largest sale of all time was on 2022-03-23 and amounted to 10722 shares of Gossamer Bio, Inc. for $95,587.

Biography of Giraudo Bryan

No biography is available at this moment.

2024-06-18PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
100,000
0.0512%
$0.59$59,110+71.39%
2024-03-27SaleGossamer Bio, Inc.
GOSS
COO/CFO
6,430
0.0028%
$1.16$7,431-24.79%
2023-11-13PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
200,000
0.0795%
$0.56$112,880+40.96%
2023-04-04PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
55,000
0.0583%
$1.02$56,095+3.45%
2022-07-15PurchaseGossamer Bio, Inc.
GOSS
COO/CFO
13,869
0.0099%
$7.21$99,995-79.92%
2022-03-23SaleGossamer Bio, Inc.
GOSS
COO/CFO
10,722
0.0143%
$8.91$95,587-4.09%
2021-03-23SaleGossamer Bio, Inc.
GOSS
Chief Financial Officer
5,490
0.0077%
$9.48$52,046+1.54%
2020-10-14PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
6,000
0.0094%
$10.01$60,072-1.07%
2020-06-23PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
4,000
0.0061%
$12.96$51,845-21.51%
2019-12-03PurchaseProtagonist Therapeutics, Inc.
PTGX
director
16,000
0.0705%
$5.70$91,240+243.28%
2019-09-26PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
2,242
0.0019%
$8.39$18,810-14.76%
2019-05-30PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
2,000
0.0017%
$9.35$18,700-11.88%
2019-02-12PurchaseGossamer Bio, Inc.
GOSS
Chief Financial Officer
12,000
0.0286%
$16.00$192,000+6.27%
2017-05-16PurchaseProtagonist Therapeutics, Inc.
PTGX
director
10,000
0.0357%
$6.46$64,566+46.97%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.